Difficulty: Medium
Average Score: 89%
Practice
Which Opiate Replacement Therapy is least appropriate during pregnancy?
Correct answer
D
Rationale
In early pregnancy, the least appropriate opiate replacement therapy is D) Buprenorphine and Naloxone.
Buprenorphine and Naloxone combination therapy is contraindicated in pregnancy due to the presence of Naloxone, which can precipitate withdrawal symptoms in the fetus. Methadone (option A) is considered safe for use in pregnancy and is often the preferred option for opiate replacement therapy due to its long-standing safety record. Heroin (option B) is illicit and not a recommended option for opiate replacement therapy during pregnancy. Buprenorphine (option C) is also considered safe for use during pregnancy and is an alternative to methadone in some cases.
Educationally, it is crucial to understand the implications of different opiate replacement therapies during pregnancy to ensure the safety and well-being of both the mother and the fetus. Healthcare providers need to be knowledgeable about the appropriate medications to use in this population to optimize outcomes and minimize risks. Counseling and support services should also be provided to pregnant individuals with opiate use disorders to address their specific needs during this critical period.
Buprenorphine and Naloxone combination therapy is contraindicated in pregnancy due to the presence of Naloxone, which can precipitate withdrawal symptoms in the fetus. Methadone (option A) is considered safe for use in pregnancy and is often the preferred option for opiate replacement therapy due to its long-standing safety record. Heroin (option B) is illicit and not a recommended option for opiate replacement therapy during pregnancy. Buprenorphine (option C) is also considered safe for use during pregnancy and is an alternative to methadone in some cases.
Educationally, it is crucial to understand the implications of different opiate replacement therapies during pregnancy to ensure the safety and well-being of both the mother and the fetus. Healthcare providers need to be knowledgeable about the appropriate medications to use in this population to optimize outcomes and minimize risks. Counseling and support services should also be provided to pregnant individuals with opiate use disorders to address their specific needs during this critical period.